These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22348365)

  • 61. An overview of the oral medicines used in the management of type 2 diabetes.
    Stewart M
    Nurs Stand; 2022 Jan; 37(1):54-60. PubMed ID: 34846106
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An update on the comparative effectiveness and safety of medications for type 2 diabetes.
    Goldstein MR; Mascitelli L
    Ann Intern Med; 2011 Oct; 155(8):562-3; author reply 563. PubMed ID: 22007052
    [No Abstract]   [Full Text] [Related]  

  • 63. CHAPTER 5. Clinical guideline for pharmacological management of adults with type 2 diabetes.
    Ganda OP; Segal A; Blair E; Beaser R; Gaglia J; Halprin E; Gabbay RA;
    Am J Manag Care; 2018 Jun; 24(7 Spec No.):SP253-SP262. PubMed ID: 29938998
    [No Abstract]   [Full Text] [Related]  

  • 64. [Changing paradigm in the management of type 2 diabetes Changing paradigm in the management of type 2 diabetes Changing paradigm in the management of type 2 diabetes Changing paradigm in the management of type 2 diabetes Changing paradigm in the management of type 2 diabetes].
    Prasad K
    Ceylon Med J; 2022 Sep; 67(3):71-74. PubMed ID: 37930131
    [No Abstract]   [Full Text] [Related]  

  • 65. [Blood glucose control and mortality in type 1 diabetes].
    Seguí Díaz M
    Semergen; 2015 Oct; 41(7):397-8. PubMed ID: 25816980
    [No Abstract]   [Full Text] [Related]  

  • 66. New Medications for the Treatment of Diabetes.
    Garg SK; Rodriguez E; Hirsch IB
    Diabetes Technol Ther; 2023 Feb; 25(S1):S207-S216. PubMed ID: 36802185
    [No Abstract]   [Full Text] [Related]  

  • 67. The diabetic school bus driver. Dissenting opinion.
    Potter DM
    Diabetes Care; 1988 Oct; 11(9):749-50. PubMed ID: 3224547
    [No Abstract]   [Full Text] [Related]  

  • 68. New Medications for the Treatment of Diabetes.
    Garg SK; Hirsch IB
    Diabetes Technol Ther; 2021 Jun; 23(S2):S185-S197. PubMed ID: 34061636
    [No Abstract]   [Full Text] [Related]  

  • 69. New Medications for the Treatment of Diabetes.
    Garg SK; Rodriguez E; Shah VN; Hirsch IB
    Diabetes Technol Ther; 2022 Mar; 24(S1):S190-S208. PubMed ID: 35475687
    [No Abstract]   [Full Text] [Related]  

  • 70. Are adverse drug reactions to anti-diabetic drugs more common in patients whose treatment do not adhere to diabetes management clinical guidelines? Comments on a study report.
    Rezaie Z; Taghizadeh-Ghehi M; Jafarzadeh Kohneloo A
    Eur J Clin Pharmacol; 2021 Sep; 77(9):1429-1430. PubMed ID: 33811492
    [No Abstract]   [Full Text] [Related]  

  • 71. Regarding the survey on perioperative diabetes medications and glucose control.
    Raghuraman MS
    Can J Anaesth; 2020 Jan; 67(1):154-155. PubMed ID: 31190142
    [No Abstract]   [Full Text] [Related]  

  • 72. In reply: Regarding the survey on perioperative diabetes medications and glucose control.
    Brown R; Siddiqui U; Paul J
    Can J Anaesth; 2020 Jan; 67(1):156-157. PubMed ID: 31175612
    [No Abstract]   [Full Text] [Related]  

  • 73. Chapter 4: Blood pressure management in CKD ND patients with diabetes mellitus.
    Kidney Int Suppl (2011); 2012 Dec; 2(5):363-369. PubMed ID: 25018963
    [No Abstract]   [Full Text] [Related]  

  • 74. Chapter 3: Blood pressure management in CKD ND patients without diabetes mellitus.
    Kidney Int Suppl (2011); 2012 Dec; 2(5):357-362. PubMed ID: 25018962
    [No Abstract]   [Full Text] [Related]  

  • 75. Antidiabetic medications in patients with type 2 diabetes mellitus and severe renal impairment: an update.
    Aperis G
    J Ren Care; 2012 Sep; 38(3):170-1. PubMed ID: 22883390
    [No Abstract]   [Full Text] [Related]  

  • 76. Pharmacological management of type 2 diabetes mellitus in patients with CKD.
    Hamilton CA
    J Ren Care; 2012 Feb; 38 Suppl 1():59-66. PubMed ID: 22348365
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease.
    Snyder RW; Berns JS
    Semin Dial; 2004; 17(5):365-70. PubMed ID: 15461745
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Review: metformin: potential benefits and use in chronic kidney disease.
    Pilmore HL
    Nephrology (Carlton); 2010 Jun; 15(4):412-8. PubMed ID: 20609092
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Novel hypoglycaemic agents: considerations in patients with chronic kidney disease.
    Game F
    Nephron Clin Pract; 2014; 126(1):14-8. PubMed ID: 24434725
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Use of oral hypoglycemic agents in patients with chronic kidney failure].
    Libardi F; Sirolli V; Cappelli P; Bonomini M
    G Ital Nefrol; 2009; 26(6):679-85. PubMed ID: 19918750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.